Webinar: 45% Faster Searches, Fewer Failed Experiments: A Data-Driven Approach to Antibody Selection

In this webinar, we share data-driven strategies for antibody selection to help reduce failed experiments and save hours of tedious manual searching. Dr Andrew Chalmers (CiteAb CEO and co-founder) and Dr Dres Damgaard (Principal Scientist Novo Nordisk) discuss antibody selection in practice, sharing insights into Dres’ experience from the lab - what data he looks for when selecting antibodies for research, the risks, and what can happen after purchasing. Andrew also gives a short demo of the CiteAb Explore platform to accelerate antibody selection workflows. Learn more about CiteAb or try out a search for yourself here: https://www.citeab.com/